Monteiro, J.F.; Fernandes, A.; Tato, D.G.; Moreira, E.; Ribeiro, R.; Reguengo, H.; Gonçalves, J.; Fresco, P.
Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers 2025, 17, 3262.
https://doi.org/10.3390/cancers17193262
AMA Style
Monteiro JF, Fernandes A, Tato DG, Moreira E, Ribeiro R, Reguengo H, Gonçalves J, Fresco P.
Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers. 2025; 17(19):3262.
https://doi.org/10.3390/cancers17193262
Chicago/Turabian Style
Monteiro, Joaquim Faria, Alexandrina Fernandes, Diogo Gavina Tato, Elias Moreira, Ricardo Ribeiro, Henrique Reguengo, Jorge Gonçalves, and Paula Fresco.
2025. "Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring" Cancers 17, no. 19: 3262.
https://doi.org/10.3390/cancers17193262
APA Style
Monteiro, J. F., Fernandes, A., Tato, D. G., Moreira, E., Ribeiro, R., Reguengo, H., Gonçalves, J., & Fresco, P.
(2025). Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers, 17(19), 3262.
https://doi.org/10.3390/cancers17193262
